Hikma’s diversified business delivers resilient H1 performance 3 min read People and Community Hikma’s diversified business delivers resilient H1 performance AETOSWire August 4, 2022 London, United Kingdom — Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its...Read More
